---
$id: https://graph.org.ai/products/commodity/51282307
$type: Product
source: UNSPSC
code: "51282307"
title: "Lexithromycin"
class: "51282300"
classTitle: "Erythromycins"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lexithromycin

**UNSPSC Code**: 51282307
**Class**: [Erythromycins](Erythromycins.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a macrolide antibiotic with the molecular formula C38H70N2O13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7QKO29734U, chemically known as erythromycin, 9-(o-methyloxime) but generally known as lexithromycin, which bears US NIH Compound Identifier 9570610. European Medicines Agency schedules Lexithromycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08499MIG. The term LEXITHROMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). LEXITHROMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lexithromycin under HS 29415000 and SITC 54139. As of Q4 2014, LEXITHROMYCIN remains the US FDA Preferred Term for this commodity. Lexithromycin bears US NLM identifiers UMLS ID C2981357 and NCI Concept Code C87760. SMILES: O(C1C(C(OC2OC(C(O)C(OC)(C2)C)C)C(C(=O)OC(C(O)(C(O)C(C(=N\OC)\C(CC1(O)C)C)C)C)CC)C)C)C1OC(CC(N(C)C)C1O)C.

